Nebulizers-Medical Devices Pipeline Product Landscape, 2021

Nebulizers-Medical Devices Pipeline Product Landscape, 2021

  • GlobalData
  • March 2021
  • Medical Devices
  • 50 pages

Report Description

GlobalData's Medical Devices sector report, Nebulizers - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Nebulizers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Nebulizer is a device which helps in direct delivery of medicine in case of respiratory disorders. It turns liquid medicine into mist (aerosol) to treat asthma, COPD, cystic fibrosis, and other respiratory disorders.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nebulizers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nebulizers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the products current stage of development, territory and estimated launch date

Have query on this report?

Make an Enquiry

Table of Contents

1 Introduction

1.1 Nebulizers Overview

2 Products under Development
2.1 Nebulizers - Pipeline Products by Stage of Development
2.2 Nebulizers - Pipeline Products by Segment
2.3 Nebulizers - Pipeline Products by Territory
2.4 Nebulizers - Pipeline Products by Regulatory Path
2.5 Nebulizers - Pipeline Products by Estimated Approval Date
2.6 Nebulizers - Ongoing Clinical Trials

3 Nebulizers - Pipeline Products under Development by Companies
3.1 Nebulizers Companies - Pipeline Products by Stage of Development
3.2 Nebulizers - Pipeline Products by Stage of Development

4 Nebulizers Companies and Product Overview
4.1 Ablynx NV Company Overview
4.2 Aeon Research & Technology Company Overview
4.3 AFT Pharmaceuticals Ltd Company Overview
4.4 Aura Medical Company Overview
4.5 Baby's Breath Ltd. Company Overview
4.6 Bridgesource Medical Corp Company Overview
4.7 Creare LLC Company Overview
4.8 DesignWise Medical Inc (Inactive) Company Overview
4.9 HCmed Innovations Co Ltd Company Overview
4.10 Marquette University Company Overview
4.11 Parion Sciences Inc Company Overview
4.12 RMIT University Company Overview
4.13 SolAeroMed Inc Company Overview
4.14 Stirling Pharma Inc Company Overview
4.15 Teleflex Inc Company Overview
4.16 University of California San Diego Company Overview
4.17 University of Texas Medical Branch at Galveston Company Overview
4.18 Verona Pharma Plc Company Overview
4.19 Vincent Medical Holdings Ltd Company Overview
4.20 Wellinks Inc Company Overview

5 Nebulizers- Recent Developments
5.1 Feb 17, 2021: U of Ms Technological Leadership Institute names Professor Allison Hubel new director
5.2 Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
5.3 Feb 16, 2021: Owens & Minor will Report Fourth Quarter & Full Year Financial Results on Wednesday, February 24, 2021
5.4 Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
5.5 Feb 05, 2021: Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021
5.6 Feb 04, 2021: Cardinal Health Earnings Preview
5.7 Jan 12, 2021: Vectura Group: Trading update
5.8 Sep 09, 2020: AstraZeneca Alliance and NEBUCOR nebulizers subscribe for the benefit of asthma patients

6 Appendix
6.1 Methodology
6.2 About GlobalData
6.3 Contact Us
6.4 Disclaimer

List of Tables

Nebulizers - Pipeline Products by Stage of Development
Nebulizers - Pipeline Products by Segment
Nebulizers - Pipeline Products by Territory
Nebulizers - Pipeline Products by Regulatory Path
Nebulizers - Pipeline Products by Estimated Approval Date
Nebulizers - Ongoing Clinical Trials
Nebulizers Companies - Pipeline Products by Stage of Development
Nebulizers - Pipeline Products by Stage of Development
Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
Customised Infant Inhalation Device - Product Status
Customised Infant Inhalation Device - Product Description
Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
LYNX Nebulizer - Product Status
LYNX Nebulizer - Product Description
AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
NasoSURF - Product Status
NasoSURF - Product Description
AFT Pharmaceuticals Ltd - Ongoing Clinical Trials Overview
NasoSURF - A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers
Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
Nebican - Product Status
Nebican - Product Description
Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
WiseAir - Product Status
WiseAir - Product Description
Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Breath-Adaptive Nebulizer - Product Status
Breath-Adaptive Nebulizer - Product Description
Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
DDC-Based Nebulizer - Product Status
DDC-Based Nebulizer - Product Description
DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Self-Contained Nebulizer System - Product Status
Self-Contained Nebulizer System - Product Description
HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
AdheResp - Product Status
AdheResp - Product Description
Marquette University Pipeline Products & Ongoing Clinical Trials Overview
Human Powered Nebulizer - Product Status
Human Powered Nebulizer - Product Description
Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
tPAD Device - Product Status
tPAD Device - Product Description
RMIT University Pipeline Products & Ongoing Clinical Trials Overview
UAS Nebulizer - Product Status
UAS Nebulizer - Product Description
SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
S1226 Neublizer System - Product Status
S1226 Neublizer System - Product Description
Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
High Density Aerosol Drug Delivery Device - Product Status
High Density Aerosol Drug Delivery Device - Product Description
Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
TURBOMIST - Product Status
TURBOMIST - Product Description
University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
Nebulizer - Product Status
Nebulizer - Product Description
University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
Pulse Drug Nebulization System - Product Status
Pulse Drug Nebulization System - Product Description
Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
RPL554 Nebulizer - Product Status
RPL554 Nebulizer - Product Description
Verona Pharma Plc - Ongoing Clinical Trials Overview
RPL554 Nebulizer - A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 weeks (with a 48-week Safety Subset) in Subjects with Moderate to Severe COPD
RPL554 Nebulizer - A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 Weeks in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
Home Use Ultrasonic Nebulizer - Product Status
Home Use Ultrasonic Nebulizer - Product Description
Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview
Bluetooth Enabled Flyp Nebulizer - Product Status
Bluetooth Enabled Flyp Nebulizer - Product Description
Glossary

Success Stories

Our Clients